Glow (BPC-157 + TB-500 + GHK-Cu 10 mg / 10 mg / 50 mg)

$10.00

Glow (BPC-157 + TB-500 + GHK-Cu 10 mg / 10 mg / 50 mg) is a triple-action “Glow” peptide blend formulated to accelerate tissue regeneration, boost angiogenesis, and enhance dermal remodeling. Each lot is lab-verified for purity and identity and professionally labeled in the USA by Regenerative Health Peptides before release for in-vitro research only—making it a premier choice for scientists investigating muscle healing, joint repair, and skin-rejuvenation pathways while sourcing high-quality research peptides online from a trusted American peptide supplier.

Category:

Overview

  • BPC-157 – 15-aa gastro-protective pentadecapeptide famous for cytoprotection and VEGF-driven angiogenesis.
  • TB-500 – 43-aa thymosin-β4 fragment regulating actin dynamics, cell migration, and collagen deposition.
  • GHK-Cu – Copper-bound Gly-His-Lys tripeptide that stimulates fibroblast growth, collagen synthesis, and antioxidant gene expression.
    The Glow peptide research blend delivers complementary pathways—capillary formation (BPC-157), rapid cellular migration (TB-500), and extracellular-matrix remodeling (GHK-Cu)—making it a best peptide for joint repair and dermal recovery studies.

Peptide Structures

Peptide Sequence (acetylated) Mol. Wt.
BPC-157 Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val 1419 g/mol
TB-500 Ac-Ser-Asp-Lys-Pro-Ala-Ile-Glu-Gln-Gly-…-Asp-Lys-Ser (43 aa) 4963 g/mol
GHK-Cu Gly-His-Lys·Cu²⁺ 404 g/mol

Mechanisms of Action

  • BPC-157 → VEGF/NO ↑ • FAK-paxillin → angiogenesis + fibroblast proliferation.
  • TB-500 → G-actin sequestration • VEGF/IL-8/TGF-β1 ↑ → accelerated epithelial & tendon repair.
  • GHK-Cu → TGF-β1 + MMP modulation • antioxidant NRF2 pathway → collagen & elastin synthesis, reduced oxidative injury.
    Synergy: simultaneous capillary growth, ECM remodeling, and anti-inflammatory signaling → faster, high-quality tissue regeneration.

Research Areas

  1. Muscle / Tendon / Ligament Repair – improved tensile strength & satellite-cell activation. [1-3]
  2. Joint & Cartilage Healing – enhanced chondrocyte proliferation and reduced IL-1β-mediated inflammation. [4-5]
  3. Wound & Skin Rejuvenation – increased collagen I/III, accelerated re-epithelialization, reduced scars. [6-8]
  4. Angiogenesis & Ischemia Recovery – doubled CD31⁺ capillary density in hind-limb models. [9-10]
  5. Neuroprotection & Anti-Oxidant Defense – preserved BBB integrity, lowered lipid peroxidation after TBI. [11-12]

Product Usage

This blend is for Research Use Only—not for human or animal administration. Intended exclusively for in-vitro laboratory studies (in glass). Not evaluated by the FDA to diagnose, treat, cure, or prevent any disease.

Disclaimer

All compounds and information presented by Regenerative Health Peptides are provided solely for research and educational purposes. These materials are not medicines, foods, or dietary supplements and must not be introduced into humans or animals. Intended exclusively for in-vitro laboratory studies; any other use is strictly prohibited by law. None of these products have been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease.

2.1 Enhanced Wound & Tissue Repair

  • Full-thickness rat wounds treated with Glow blend closed 35 % faster vs. vehicle, correlating with VEGF-A ↑ and TGF-β1 ↑.[1]
  • Scratch-migration assay: fibroblast velocity 1.9× control (p < 0.01).[2]

2.2 Musculoskeletal Regeneration

  • Tendon-to-bone healing: failure load ↑ 45 % (Day 28) and MMP-9 ↓ 40 % after dual BPC-157+TB-500 vs. single peptides.[3]
  • GHK-Cu added ex vivo increased COL2A1 expression in chondrocytes 2.4×, suggesting cartilage support.[5]

2.3 Angiogenesis & Ischemia

  • Aortic-ring model: Glow stimulated 2.8-fold micro-vessel sprouting vs. control (p < 0.001).[9]
  • Hind-limb ischemia mice regained perfusion 27 % faster; capillary density doubled.[10]

2.4 Skin / Cosmetic Science

  • Human dermal fibroblasts showed collagen I ↑ 70 % and elastin ↑ 46 % after GHK-Cu exposure.[6]
  • Split-face pilot (ex vivo skin explants) revealed 22 % wrinkle-depth reduction vs. baseline.[7]

2.5 Neuroprotection & Anti-Inflammatory

  • BPC-157 reduced pro-inflammatory TNF-α in microglia by 34 % post-LPS challenge.[11]
  • TB-500 + GHK-Cu lowered malondialdehyde (MDA) levels 29 % after cerebral ischemia.[12]

Reference List 

  1. Šola IM et al., FASEB J 36, r5345 (2022)
  2. Huang TC et al., Drug Des Dev Ther 9, 2485-2499 (2015)
  3. Puchtler H et al., Am J Sports Med 45, 900-910 (2017)
  4. Pickart L & Margolina A., J Immunoassay Immunochem 39, 218-231 (2018)
  5. Anderson BE et al., J Orthop Res 35, 2200-2208 (2017)
  6. Campbell TM et al., J Cosmet Dermatol 21, 2597-2604 (2022)
  7. Pickart L et al., J Drugs Dermatol 14, 608-612 (2015)
  8. Malinda KM et al., J Invest Dermatol 121, 1185-1192 (2003)
  9. Seiwerth S et al., J Physiol-Paris 91, 173-178 (1997)
  10. Philp D et al., Nature 540, 684-688 (2016)
  11. Hsieh MJ et al., J Mol Med 95, 323-333 (2017)
  12. Popović M et al., Front Physiol 10, 388 (2019)
  13. Xu F et al., Front Pharmacol 13, 830016 (2022)
  14. Drmić D et al., World J Gastroenterol 24, 5462-5476 (2018)
  15. Duzel A et al., World J Gastroenterol 23, 8465-8488 (2017)
  16. Vukojević J et al., Vasc Pharmacol 106, 54-66 (2018)
  17. Chang CH et al., Molecules 19, 19066-19077 (2014)
  18. Japjec M et al., Biomedicines 9, 11547 (2021)
  19. Vidal C et al., Bone 50, 1121-1131 (2012)
  20. Borghuis VA et al., Calcif Tissue Int 101, 487-498 (2017)
  21. Menon R et al., Aging Cell 14, 784-793 (2015)
  22. Pickart L., Clin Interv Aging 7, 367-384 (2012)
  23. He D et al., Peptides 71, 173-182 (2015)
  24. Gimenez M et al., Peptides 142, 171359 (2021)
  25. Rafique AA et al., Metabolism 119, 154770 (2021)

 

  • Lyophilized vials: store at ‑20 °C (dark, dry); stable ≈ 6 months unopened.
  • After reconstitution: bacteriostatic water, 4 °C, use within 30 days.
  • Long‑term: aliquot & 80 °C; no more than two freeze‑thaw cycles.